Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MFC51123 skin irritation study
NCT02169154Phase 1Completed
- Sponsor
- GSK
- Start
- Jun 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of diclofenac and l-Menthol in sprain, muscle strain and sports injuries (7 arms), sponsored by GSK. Primary endpoints: Treatment mean cumulative irritation score at Day 21 and Adverse event assessment at 26 days. Started Jun 2014; status: completed.
02
Drugs
diclofenacl-Menthol
03
Conditions
sprainmuscle strainsports injuries
Beyond the preview
Go deeper on NCT02169154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169154.